<DOC>
	<DOCNO>NCT00579371</DOCNO>
	<brief_summary>We hypothesize follow improvement islet transplantation increase islet mass successfully isolate allow engraftment single pancreas . The improvement : - Using Two-Layer method preservation improve pancreas quality islet isolation - Maintaining isolated islet culture transplantation - Using steroid-free immunosuppression regimen - Transplanting best combination donor recipient possible HLA screen final crossmatching</brief_summary>
	<brief_title>Cadaveric Islet Transplantation Patients With Insulin-Dependent Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Group 1 : Diagnosis Type1 diabetes mellitus 5 year least one follow complication : Metabolic lability/instability ( two episode severe hypoglycemia ) two hospital visit diabetic ketoacidosis previous year Progression secondary complication diabetes determine The Nebraska Medical Center/University Nebraska Medical Center staff endocrinologists Group 2 : Diagnosis Type1 diabetes successful renal transplant steroidfree , FK506/rapamycinbased immunosuppression Severe coexist cardiac disease Active alcohol substance abuse , include cigarette smoking Psychiatric disorder make subject suitable candidate transplantation History medical noncompliance Active infection , include hepatitis C B , HIV , tuberculosis ( suspected tuberculosis ) Any history malignancy except squamous basal cell skin cancer BMI &gt; 28 kg/metersquared , body weight &gt; 80kg screen visit , &gt; 85kg day transplantation ( due difficulty obtain sufficiently large islet mass adequately treat either large patient whose obesity elevate insulin need ) Positive Cpeptide response intravenous glucose tolerance test Mixed Meal glucose tolerance test : Cpeptide &gt; 0.3 ng/mL post infusion Inability provide inform consent Age le 19 great 70 year Creatinine clearance &lt; 60 mL/min/1.73 metersquared Group 1 creatinine clearance &lt; 40 mL/min/1.73 metersquared Group 2 ( subject currently immunosuppression due previous kidney transplant ) Macroalbuminuria ( urinary albumin excretion rate &gt; 300 mg/24h ) Group 1 macroalbuminuria ( urinary albumin excretion rate &gt; 600mg/24h ) Group 2 Baseline Hb &lt; 10 gm/dL Baseline liver function test outside normal range Presence gallstone hemangioma liver baseline ultrasound exam Positive pregnancy test , intention future pregnancy , presently breastfeed Evidence sensitization PRA Insulin requirement &gt; 0.7 IU/kg/day HbA1c &gt; 15 % Hyperlipidemia Under treatment medical condition require chronic use steroid Use Coumadin anticoagulant therapy ( except aspirin ) PTINR &gt; 1.5 Diagnosis Addison 's disease Additional Exclusion Criteria Group 2 Subjects : Any history organ transplantation kidney pancreas Any previous graft lose rejection Any history early , multiple , vascular renal allograft rejection</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>islet transplantation</keyword>
	<keyword>type 1 diabetes mellitus</keyword>
	<keyword>steroid-free immunosuppression</keyword>
	<keyword>rabbit anti-thymocyte globulin</keyword>
</DOC>